Join us for a unique summit tackling the latest issues in valve disease, structural interventions, and advanced imaging including Diastology, strain and 3-D imaging, as well as artificial intelligence.

The 25th Cleveland Clinic Valve Disease, Structural Interventions, and Diastology/Imaging Summit will focus on mitral, aortic and tricuspid valve diseases, as well as the latest advances in structural interventions including TAVR, percutaneous edge to edge repair, valve-in-valve procedures and LAA occluder devices. This summit will include case-based lectures and workshops about strain, 3-D and contrast echo.

This will provide you a unique opportunity to receive updates in new and emerging topics from basic to advanced imaging techniques, including 3-D echocardiography, strain imaging, interventional echo as well as MRI/CT. New guidelines will be discussed, as well as advances in pericardial, myocardial diseases and congenital heart disease.

There will be controversies on topics in valve disease and structural heart disease, as well
artificial intelligence.

By Attending, You Will Be Able To:

• Apply echocardiography to assess the severity, mechanism, etiology, and hemodynamic impact of the many types of valve disease, including mitral regurgitation, mitral stenosis, aortic stenosis, aortic regurgitation, and tricuspid valve disorders.
• Assess the most recent innovations in structural interventions and describe their clinical use.
• Translate new guideline criteria on imaging into current decision-making regarding structural valve interventions, medical treatment, and surgical valve repair/replacement.
• Utilize echocardiographic imaging for imaging before, during, and after interventional procedures, closure of periprosthetic leaks, valve-in-valve repair, left atrial appendage closure, and tricuspid repair.
• Provide an update on multimodality imaging techniques, including 3-D echocardiography, fusion imaging, strain imaging, MRI/CT as well as contrast echo.
• Describe clinical methods to diagnose diastolic dysfunction and manage disorders such as heart failure with preserved ejection fraction, cardiac amyloidosis, complicated pericarditis, and hypertrophic cardiomyopathy.
• Define what artificial intelligence is and how to use it in clinical practice.
• Discuss the clinical indications and emerging uses of contrast echocardiography.

Who Should Attend:

Noninvasive and invasive cardiologists, cardiac surgeons, anesthesiologists, sonographers, nurses, fellows, cardiology nurse practitioners, and physician assistants will benefit from attending this summit